FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290775002> ?p ?o ?g. }

• W4290775002 endingPage "1210" @default.
• W4290775002 startingPage "1201" @default.
• W4290775002 abstract "Evidence for the cardiorenal risk reduction properties of antihyperglycemic medications originally prescribed for type 2 diabetes, sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) is rapidly emerging. We completed a meta-analysis of recent literature to provide evidence-based estimates of benefit across various populations and outcomes.We searched Medline and Cochrane databases from 2015 to September 2021 for randomized controlled trials of SGLT2i and GLP-1RA with placebo control. Reviewers screened citations, extracted data, and assessed the risk of bias and certainty of evidence. We assessed statistical and methodological heterogeneity and performed a meta-analysis of studies with similar interventions and components.A total of 137,621 adults (51% male) from 19 studies were included; 14 studies with unclear risk of bias and 5 with low risk of bias. Compared with standard of care, use of SGLT2i showed significant reductions for the outcome of cardiovascular (CV) mortality (14%), any-cause mortality (13%), major adverse CV events (MACE) (12%), heart failure (HF) hospitalization (31%), CV death or HF hospitalization (24%), nonfatal myocardial infarction (10%), and kidney composite outcome (36%). Treatment with GLP-1RA was associated with significant reductions for the outcome of CV mortality (13%), any-cause mortality (12%), MACE (14%), CV death or HF hospitalization (11%), nonfatal stroke (16%), and kidney composite outcome (22%).The use of GLP-1RA and SGLT2i leads to a statistically significant benefit across most cardiorenal outcomes in the populations studied. This review shows a role for SGLT2i and GLP-1RA in cardiorenal protection in adults, independent of type 2 diabetes status." @default.
• W4290775002 created "2022-08-09" @default.
• W4290775002 creator A5004040948 @default.
• W4290775002 creator A5004388282 @default.
• W4290775002 creator A5008046266 @default.
• W4290775002 creator A5018617988 @default.
• W4290775002 creator A5020075219 @default.
• W4290775002 creator A5024418476 @default.
• W4290775002 creator A5030053531 @default.
• W4290775002 creator A5060475589 @default.
• W4290775002 creator A5080474368 @default.
• W4290775002 date "2022-08-01" @default.
• W4290775002 modified "2023-10-12" @default.
• W4290775002 title "The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis" @default.
• W4290775002 cites W2098923148 @default.
• W4290775002 cites W2107328434 @default.
• W4290775002 cites W2146264128 @default.
• W4290775002 cites W2282578582 @default.
• W4290775002 cites W2425644022 @default.
• W4290775002 cites W2519510391 @default.
• W4290775002 cites W2532414435 @default.
• W4290775002 cites W2576440140 @default.
• W4290775002 cites W2626446274 @default.
• W4290775002 cites W2754041380 @default.
• W4290775002 cites W2758716852 @default.
• W4290775002 cites W2894746763 @default.
• W4290775002 cites W2900413769 @default.
• W4290775002 cites W2939222610 @default.
• W4290775002 cites W2948579396 @default.
• W4290775002 cites W2948612418 @default.
• W4290775002 cites W2974260792 @default.
• W4290775002 cites W3081830235 @default.
• W4290775002 cites W3088173406 @default.
• W4290775002 cites W3089283105 @default.
• W4290775002 cites W3100542962 @default.
• W4290775002 cites W3101044784 @default.
• W4290775002 cites W3177365549 @default.
• W4290775002 cites W3193297191 @default.
• W4290775002 cites W4206445899 @default.
• W4290775002 cites W4290776063 @default.
• W4290775002 doi "https://doi.org/10.1016/j.cjca.2022.05.011" @default.
• W4290775002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35961756" @default.
• W4290775002 hasPublicationYear "2022" @default.
• W4290775002 type Work @default.
• W4290775002 citedByCount "10" @default.
• W4290775002 countsByYear W42907750022022 @default.
• W4290775002 countsByYear W42907750022023 @default.
• W4290775002 crossrefType "journal-article" @default.
• W4290775002 hasAuthorship W4290775002A5004040948 @default.
• W4290775002 hasAuthorship W4290775002A5004388282 @default.
• W4290775002 hasAuthorship W4290775002A5008046266 @default.
• W4290775002 hasAuthorship W4290775002A5018617988 @default.
• W4290775002 hasAuthorship W4290775002A5020075219 @default.
• W4290775002 hasAuthorship W4290775002A5024418476 @default.
• W4290775002 hasAuthorship W4290775002A5030053531 @default.
• W4290775002 hasAuthorship W4290775002A5060475589 @default.
• W4290775002 hasAuthorship W4290775002A5080474368 @default.
• W4290775002 hasBestOaLocation W42907750021 @default.
• W4290775002 hasConcept C126322002 @default.
• W4290775002 hasConcept C127413603 @default.
• W4290775002 hasConcept C134018914 @default.
• W4290775002 hasConcept C142724271 @default.
• W4290775002 hasConcept C168563851 @default.
• W4290775002 hasConcept C204787440 @default.
• W4290775002 hasConcept C27081682 @default.
• W4290775002 hasConcept C2777180221 @default.
• W4290775002 hasConcept C2777451236 @default.
• W4290775002 hasConcept C2778198053 @default.
• W4290775002 hasConcept C2780645631 @default.
• W4290775002 hasConcept C2780739214 @default.
• W4290775002 hasConcept C45393284 @default.
• W4290775002 hasConcept C500558357 @default.
• W4290775002 hasConcept C555293320 @default.
• W4290775002 hasConcept C71924100 @default.
• W4290775002 hasConcept C78519656 @default.
• W4290775002 hasConcept C95190672 @default.
• W4290775002 hasConceptScore W4290775002C126322002 @default.
• W4290775002 hasConceptScore W4290775002C127413603 @default.
• W4290775002 hasConceptScore W4290775002C134018914 @default.
• W4290775002 hasConceptScore W4290775002C142724271 @default.
• W4290775002 hasConceptScore W4290775002C168563851 @default.
• W4290775002 hasConceptScore W4290775002C204787440 @default.
• W4290775002 hasConceptScore W4290775002C27081682 @default.
• W4290775002 hasConceptScore W4290775002C2777180221 @default.
• W4290775002 hasConceptScore W4290775002C2777451236 @default.
• W4290775002 hasConceptScore W4290775002C2778198053 @default.
• W4290775002 hasConceptScore W4290775002C2780645631 @default.
• W4290775002 hasConceptScore W4290775002C2780739214 @default.
• W4290775002 hasConceptScore W4290775002C45393284 @default.
• W4290775002 hasConceptScore W4290775002C500558357 @default.
• W4290775002 hasConceptScore W4290775002C555293320 @default.
• W4290775002 hasConceptScore W4290775002C71924100 @default.
• W4290775002 hasConceptScore W4290775002C78519656 @default.
• W4290775002 hasConceptScore W4290775002C95190672 @default.
• W4290775002 hasFunder F4320314322 @default.
• W4290775002 hasIssue "8" @default.
• W4290775002 hasLocation W42907750021 @default.
• W4290775002 hasLocation W42907750022 @default.

• next